Big Move For Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. (RETA:NASDAQ) rocketted at $93.17, a gain of 198.9%. On Wed, Mar 01, 2023, RETA:NASDAQ touched a New 2-Week High of $93.17. The stock got featured on our News Catalysts scanner on Wed, Mar 01, 2023 at 04:10 PM in the 'BIOTECH' category. From Wed, Feb 15, 2023, the stock recorded 66.67% Up Days and 70.00% Green Days
About Reata Pharmaceuticals, Inc. (RETA:NASDAQ)
Reata Pharmaceuticals Inc is a clinical stage biopharmaceutical company engaged in identifying, developing, and commercializing product candidates to address rare and life-threatening diseases by targeting molecular pathways.
Top 10 Gainers:
- Reata Pharmaceuticals, Inc. (RETA:NASDAQ), 198.91%
- HPX Corp. Class A (HPX:NYSEMKT), 173.71%
- HPX Corp. Class A (HPX:NYSE), 173.71%
- Cardio Diagnostics Holdings Inc Com (CDIO:NASDAQ), 91.3%
- OncoSec Medical Incorporated (ONCS:NASDAQ), 88.89%
- BiomX Inc. (PHGE:NYSEMKT), 43.31%
- Decarbonization Plus Acquisition Corporation IV (DCRD:NASDAQ), 40.52%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 37.72%
- Mmtec, Inc. (MTC:NASDAQ), 37.39%
- Powerbridge Technologies Co., Ltd. (PBTS:NASDAQ), 34.43%